Cytek Biosciences, Inc. · NASDAQ:CTKB
BlackRock, Inc. reported a 14.30% stake in Cytek Biosciences, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 5, 2025
BlackRock, Inc. reported a 14.30% stake in Cytek Biosciences, Inc., 18,482,795 shares, as a passive investor on Dec 31, 2024. Filed Feb 5, 2025 (Schedule 13G/A).
- Stake
- 14.30%
- Shares
- 18,482,795
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 14.30% | 18,482,795 |
Source
Related
- Cytek Biosciences, Inc.
- BlackRock, Inc.
- Cytek Biosciences, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 8, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 18, 2025
- Form 4 · Jiang Wenbin · Aug 20, 2026
- Form 4 · McCombe William D. · Aug 20, 2026
- Form 4 · Muir Glenn P · Aug 20, 2026
- Form 4 · Holder Michael · Aug 20, 2026
- Form 4 · Chin Richard · Aug 20, 2026